Article
CancerVax expects to launch its therapeutic melanoma vaccine and lead product candidate Canvaxin by 2006.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Cutibacterium acnes Dominates the Post-Laser Skin Microbiome
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Evidence Highlights Thiamidol’s Efficacy and Safety in Hyperpigmentation Treatment
Q&A: Laura Scott, MD, FAAD, and Sun Bum on the Road to Accessible Sun Safety